Resource Summary

Clinical Question:
In non-cardioembolic ischemic stroke^ should we treat with two anti-platelet agents (like adding dipyridamole or clopidogrel to ASA) or just one?

Bottom-line:
Evidence supports using single agent (ASA or clopidogrel) after stroke or transient ischemic attack. Some evidence favours combined dipyridamole and ASA (DP-ASA^ Aggrenox®) but new results question this benefit.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2014-3-17
Last Updated on PCR: 2017-03-31 14:29:18